Skip to main content

Table 1 Clinical characteristics of study subjects

From: Practice variation in anti-epileptic drug use for neonatal hypoxic-ischemic encephalopathy among regional NICUs

 

All

No Seizure

EEG Seizure

Clinical Seizure

p-value

 

1658

947

472

239

 

Gestational age in weeks Mean (SD)

38.80 (1.48)

38.74 (1.49)

38.97 (1.48)

39 (1.41)

0.010*

Birth weight in grams Median [IQR]

3290 [2940, 3700]

3295 [2940, 3715]

3270 [2890, 3635]

3310 [3000, 3720]

0.206

Female sex (n, %)

721 (43.5)

395 (41.7)

223 (47.3)

103 (43.1)

0.139

Maternal race (n, %)

    

0.007*

 White

996 (60.1)

569 (60.1)

289 (61.2)

138 (57.7)

 

 Black

350 (21.1)

217 (22.9)

92 (19.5)

41 (17.2)

 

 Asian

72 (4.3)

43 (4.5)

20 (4.2)

9 (3.8)

 

 Other

164 (9.9)

73 (7.7)

51 (10.8)

40 (16.7)

 

Delivery type (n, %)

    

0.862

 Cesarean

1069 (64.5)

617 (65.2)

301 (63.8)

151 (63.2)

 

 Vaginal, non-operative

407 (24.6)

223 (23.6)

120 (25.4)

64 (26.8)

 

 Vaginal, operative

175(10.6)

102 (10.8)

49 (10.4)

24 (10.0)

 

 Unknown

7 (0.42)

5 (0.53)

2 (0.42)

0(0)

 

Apgar score < = 5

     

 5 min Median [IQR]

3 [1,4]

3 [2,4]

2 [1,4]

2 [1,4]

<0.001*

 10 min Median [IQR]

3 [2,5]

4 [2,5]

3 [2,4]

3 [1,4]

<0.001*

 15 min Median [IQR]

3 [2,5]

4 [2,5]

3 [2,4]

2 [1,4]

0.012*

DR resuscitation

 ETT/Ventilation (n, %)

1190 (71.8)

631 (66.6)

375 (79.5)

184 (77.0)

<0.001*

 Chest compressions (n, %)

688 (41.5)

319 (33.7)

238 (50.4)

131 (54.8)

<0.001*

 Epinephrine (n, %)

375 (22.6)

156 (16.5)

144 (30.5)

75 (31.4)

<0.001*

Presenting pH♯ Median [IQR]

6.99 [6.82, 7.14]

7.02 [6.88, 7.15]

6.96 [6.80, 7.12]

6.9 [6.80, 7.10]

0.001*

Presenting BD Median [IQR]

16 [11.5, 21]

15 [11.5, 18.8]

17 [12, 22.3]

17.9 [13.3, 24.8]

0.001*

Perinatal sentinel event

 Nuchal cord (n, %)

288 (17.4)

174 (18.4)

79 (16.7)

35 (14.6)

0.36

 Cord prolapse (n, %)

54 (3.3)

31 (3.3)

11 (2.3)

12 (5.0)

0.16

 Uterine rupture (n, %)

96 (5.8)

46 (4.9)

34 (7.2)

16 (6.7)

0.17

 Placental abruption (n, %)

196 (11.8)

99 (10.5)

67 (14.2)

30 (12.6)

0.11

 Fetal distress (n, %)

362 (21.8)

232 (24.5)

91 (19.3)

39 (16.3)

0.007*

Continuous inotropes on transport/admission (n, %)

318 (19.2)

150 (15.8)

116 (24.6)

52 (21.8)

< 0.001*

Maternal antenatal conditions

 Chorioamnionitis (n, %)

140 (8.4)

78 (8.24)

49 (10.4)

13 (5.4)

0.08

 Diabetes (n, %)

198 (11.9)

126 (13.3)

36 (7.6)

36 (15.1)

0.002*

Encephalopathy severity+

    

<0.001*

 Mild (n, %)

308 (18.6)

261 (27.6)

29 (6.1)

18 (7.5)

 

 Moderate (n, %)

917 (55.3)

560 (59.1)

227 (48.1)

130 (54.4)

 

 Severe (n, %)

433 (26.1)

126 (13.3)

216 (45.8)

91 (38.1)

 

Type of cooling

    

<0.001*

 Head (n, %)

337 (20.3)

121 (12.8)

153 (32.4)

63 (26.4)

 

 Whole body (n, %)

1326 (80.0)

834 (88.1)

320 (67.8)

172 (72.0)

 

ECMO

57 (3.4)

37 (3.9)

10 (2.1)

10 (4.2)

0.17

iNO

334 (20.14)

182 (19.2)

90 (19.07)

62 (25.9)

0.05

Pre-discharge mortality (n, %)

223 (13.5)

85 (9.0)

93 (19.7)

45 (18.8)

<0.001*

Survivors hospital LOS Median [IQR]

13 [10, 22]

11 [8, 18]

15 [10, 25.5]

14 [9, 26]

<0.001*

Treated with AED (n, %)

757 (45.6)

133 (11.9)

447 (94.7)

197 (82.4)

<0.001*

Discharged on AED (n, %)

261 (20.1)

11 (1.42)

196 (56.3)

54 (30.7)

<0.001*

  1. Abbreviations: EEG electroencephalographic, IQR interquartile range, DR delivery room, ETT endotracheal tube, ECMO extracorporeal membrane oxygenation, iNO inhaled nitric oxide, LOS length of stay, AED anti-epileptic drug
  2. ♯Presenting pH = worst umbilical cord gas or arterial blood gas within 1 h of life if cord gas not available
  3. +VON or NICHD definitions of HIE were used, depending on each site’s practice; for the NICHD definition, infants with mild encephalopathy on Sarnat exam and seizures qualify for TH
  4. *p-value <=0.05